Controversies in upper GI oncology: definition and management of oligometastatic gastroesophageal adenocarcinoma
In this podcast, Dr Angelica Petrillo, GI oncologist of Ospedale del Mare, Naples (Italy), moderates a debate between Prof. Hanneke W. M. van Laarhoven, medical oncologist at the University of Amsterdam, Amsterdam (The Netherlands) and Prof. Guillaume Piessen, surgeon at Centre Hospitalier Régional Universitaire de Lille (France), regarding the definition and management of oligometastatic gastroesophageal adenocarcinoma (GEA).
Authors
- Guillaume Piessen (ORCID: https://orcid.org/0000-0001-8243-8310)
- Hanneke W.M. van Laarhoven (ORCID: https://orcid.org/0000-0003-1274-5643)
- Angelica Petrillo (ORCID: https://orcid.org/0000-0001-5489-5733)
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Lille (FR)
- Centre Hospitalier Universitaire de Lille (FR)
- CNR de la Résistance aux Antibiotiques (FR)
- Ospedale D. Cotugno (IT)
- Amsterdam University Medical Centers (NL)
- Hôpital Claude Huriez (FR)
- Cancer Center Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- ESMO Gastrointestinal Oncology
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1016/j.esmogo.2025.100228
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Amgen
- Bristol-Myers Squibb
- Stryker
- BeiGene
- Incyte
- Daiichi-Sankyo
- Astellas Pharma
- Servier